Evidence map›Paper›PMID 40160183›Full record

ArticleThe American journal of surgical pathology2025

MEIS1::NCOA1 Primitive Spindle Cell Sarcoma of the Kidney : Report of 7 Cases of a Distinctive Clinicopathologic Entity.

Pedram Argani, Sintawat Wangsiricharoen, Maria Tretiakova, Yajuan J Liu, Sara M Falzarano, Katrina Collins, Fadi Brimo, John M Gross, Ezra Baraban, Andres Matoso and 9 more

Abstract readCase Reports
In one paragraph

Article in The American journal of surgical pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Pedram ArganiDepartments of Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore, MD.
Sintawat WangsiricharoenDepartment of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR.
Maria TretiakovaDepartment of Pathology and Laboratory Medicine, University of Washington, Seattle, WA.
Yajuan J LiuDepartment of Pathology and Laboratory Medicine, University of Washington, Seattle, WA.
Sara M FalzaranoDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL.
Katrina CollinsIndiana University School of Medicine, Indianapolis, IN.
Fadi BrimoMcGill University Health Center, Montreal, QC, Canada.
John M GrossDepartments of Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore, MD.
Ezra BarabanDepartments of Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore, MD.
Andres MatosoDepartments of Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore, MD.
Kristina WakemanDepartment of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR.
Christopher CorlessDepartment of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR.
Tanaya NeffDepartment of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR.
Benjamin F SmithDepartment of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR.
Ali Abdel SatirHistoCenter, Khartoum, Sudan.
Abbas AgaimyInstitute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Comprehensive Cancer Center (CCC) Erlangen-EMN, Erlangen, Germany.
Cristina R AntonescuDepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Gregory W CharvilleDepartment of Pathology, Stanford University, Stanford, CA.
Ankur R SangoiDepartment of Pathology, Stanford University, Stanford, CA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
SPORE in Soft Tissue SarcomaP50CA140146 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI SPRIGGS, DAVID R · 2010 to 2014
$11.1M
NCI NIH HHS P30 CA008748NCI NIH HHS P50 CA140146
6 · The paper itself

Abstract

Primitive sarcomas harboring the MEIS1::NCOA2 gene fusion were originally described in the kidney in 2018, and subsequently reported in other organs. These variably cellular neoplasms feature monomorphic primitive plump spindle cells forming nodules and whorls in addition to nondescript fascicular, solid, and storiform patterns. They lack skeletal muscle differentiation in contrast to the primarily intraosseous rhabdomyosarcomas that harbor the same gene fusion. We describe 7 new primary primitive renal sarcomas with MEIS1::NCOA1 gene fusions. Although their morphology overlaps with that described in MEIS1::NCOA2 renal sarcoma, 3 of the 7 cases contained adipose tissue. The majority had intimately admixed entrapped cystic epithelial elements and demonstrated patchy immunoreactivity for estrogen receptor and nuclear labeling for WT1 protein, leading to the differential diagnosis of malignant mixed epithelial stromal tumor (MEST) in 4 cases and metanephric stromal tumor in one. The neoplasms demonstrate a broad spectrum of clinicopathologic features ranging from a bland low-grade neoplasm that metastasized 9 years after diagnosis to a high-grade sarcoma with multiple recurrences, ultimately leading to patient death in under 1 year. In summary, MEIS1::NCOA1 primitive sarcomas overlap with the previously described MEIS1::NCOA2 primitive renal sarcomas and represent a distinctive renal neoplasm that can be mistaken for malignant MEST. Grade ranges from low to high but even low-grade neoplasms require long-term clinical follow-up.

Indexed as

Biomarkers, TumorKidney NeoplasmsMyeloid Ecotropic Viral Integration Site 1 ProteinOncogene Proteins, FusionSarcomaAdultAgedFemaleHumansImmunohistochemistryMaleMiddle AgedBiomarkers, TumorMEIS1 protein, humanMyeloid Ecotropic Viral Integration Site 1 ProteinOncogene Proteins, Fusionrenal neoplasmsarcomatranslocation

Identifiers

PMID40160183
PMCPMC12715815

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.